XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Statement of Changes in Stockholders' Equity - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2020 $ 369 $ 9,083 $ 127,311,634 $ (105,563,124) $ 21,757,962
Balance (in shares) at Jun. 30, 2020 368,602 9,083,414      
Series A Preferred Stock issued for employee stock compensation     53,098   53,098
Series A Preferred Stock issued for employee stock compensation (in shares) 387        
Common stock issued for consulting and legal services rendered   $ 5 26,995   27,000
Common stock issued for consulting and legal services rendered (in shares)   5,135      
Net proceeds from issuance of common stock in connection with equity financing   $ 1,576 10,440,640   10,442,216
Net proceeds from issuance of common stock in connection with equity financing (in shares)   1,575,342      
Warrants issued to Scientific Advisory Board     1,986   1,986
Common shares issued for Directors fees   $ 2 11,248   11,250
Common shares issued for Directors fees (in shares)   2,040      
Net loss       (2,311,233) (2,311,233)
Balance at Sep. 30, 2020 $ 369 $ 10,666 137,845,601 (107,874,357) 29,982,279
Balance (in shares) at Sep. 30, 2020 368,989 10,665,931      
Balance at Jun. 30, 2020 $ 369 $ 9,083 127,311,634 (105,563,124) 21,757,962
Balance (in shares) at Jun. 30, 2020 368,602 9,083,414      
Net loss         (6,749,317)
Balance at Mar. 31, 2021 $ 371 $ 11,505 144,190,346 (112,312,441) 31,889,781
Balance (in shares) at Mar. 31, 2021 371,103 11,504,693      
Balance at Sep. 30, 2020 $ 369 $ 10,666 137,845,601 (107,874,357) 29,982,279
Balance (in shares) at Sep. 30, 2020 368,989 10,665,931      
Series A Preferred Stock issued for employee stock compensation     50,602   50,602
Series A Preferred Stock issued for employee stock compensation (in shares) 387        
Common stock issued for consulting and legal services rendered   $ 7 26,993   27,000
Common stock issued for consulting and legal services rendered (in shares)   7,411      
Warrants issued to Scientific Advisory Board     1,215   1,215
Common shares issued for Directors fees   $ 4 14,996   15,000
Common shares issued for Directors fees (in shares)   4,106      
Net loss       (2,330,054) (2,330,054)
Balance at Dec. 31, 2020 $ 369 $ 10,677 137,939,407 (110,204,411) 27,746,042
Balance (in shares) at Dec. 31, 2020 369,376 10,677,448      
Series A Preferred Stock issued for employee stock compensation $ 2   71,498   71,500
Series A Preferred Stock issued for employee stock compensation (in shares) 1,727        
Common stock issued for consulting and legal services rendered   $ 6 26,994   27,000
Common stock issued for consulting and legal services rendered (in shares)   6,131      
Net proceeds from issuance of common stock in connection with equity financing   $ 815 6,120,666   6,121,481
Net proceeds from issuance of common stock in connection with equity financing (in shares)   814,242      
Warrants issued to Scientific Advisory Board     1,750   1,750
Common stock issued for employee compensation   $ 4 15,034   15,038
Common stock issued for employee compensation (in shares)   3,572      
Common shares issued for Directors fees   $ 3 14,997   15,000
Common shares issued for Directors fees (in shares)   3,300      
Net loss       (2,108,030) (2,108,030)
Balance at Mar. 31, 2021 $ 371 $ 11,505 144,190,346 (112,312,441) 31,889,781
Balance (in shares) at Mar. 31, 2021 371,103 11,504,693      
Balance at Jun. 30, 2021 $ 372 $ 11,515 144,284,593 (114,385,313) 29,911,167
Balance (in shares) at Jun. 30, 2021 371,490 11,515,170      
Series A Preferred Stock issued for employee stock compensation $ 10 $ 0 32,880 0 32,890
Series A Preferred Stock issued for employee stock compensation (in shares) 10,591 0      
Series A preferred stock issued for license agreement $ 100   934,988   935,088
Series A preferred stock issued for license agreement (in shares) 100,000        
Common stock issued for consulting and legal services rendered   $ 6 26,994   27,000
Common stock issued for consulting and legal services rendered (in shares)   6,509      
Warrants issued to Scientific Advisory Board     1,352   1,352
Common shares issued for Directors fees   $ 4 14,996   15,000
Common shares issued for Directors fees (in shares)   3,524      
Net loss       (2,613,068) (2,613,068)
Balance at Sep. 30, 2021 $ 482 $ 11,525 145,295,803 (116,998,381) 28,309,429
Balance (in shares) at Sep. 30, 2021 482,081 11,525,203      
Balance at Jun. 30, 2021 $ 372 $ 11,515 144,284,593 (114,385,313) 29,911,167
Balance (in shares) at Jun. 30, 2021 371,490 11,515,170      
Net loss         (6,326,866)
Balance at Mar. 31, 2022 $ 484 $ 11,554 145,457,987 (120,712,179) 24,757,846
Balance (in shares) at Mar. 31, 2022 484,195 11,554,476      
Balance at Sep. 30, 2021 $ 482 $ 11,525 145,295,803 (116,998,381) 28,309,429
Balance (in shares) at Sep. 30, 2021 482,081 11,525,203      
Series A preferred stock issued for license agreement     33,367   33,367
Series A preferred stock issued for license agreement (in shares) 387        
Common stock issued for consulting and legal services rendered   $ 6 26,994   27,000
Common stock issued for consulting and legal services rendered (in shares)   5,993      
Warrants issued to Scientific Advisory Board     1,644   1,644
Common shares issued for Directors fees   $ 3 14,997   15,000
Common shares issued for Directors fees (in shares)   3,288      
Net loss       (1,921,134) (1,921,134)
Balance at Dec. 31, 2021 $ 482 $ 11,534 145,372,805 (118,919,515) 26,465,306
Balance (in shares) at Dec. 31, 2021 482,468 11,534,484      
Series A Preferred Stock issued for employee stock compensation $ 2   39,399   39,401
Series A Preferred Stock issued for employee stock compensation (in shares) 1,727        
Common stock issued for consulting and legal services rendered   $ 12 26,988   27,000
Common stock issued for consulting and legal services rendered (in shares)   11,632      
Warrants issued to Scientific Advisory Board     785   785
Common stock issued for employee compensation   $ 3 6,765   6,768
Common stock issued for employee compensation (in shares)   3,572      
Common shares issued for Directors fees   $ 5 11,245   11,250
Common shares issued for Directors fees (in shares)   4,788      
Net loss       (1,792,664) (1,792,664)
Balance at Mar. 31, 2022 $ 484 $ 11,554 $ 145,457,987 $ (120,712,179) $ 24,757,846
Balance (in shares) at Mar. 31, 2022 484,195 11,554,476